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Abstract Combined with in vitro and in vivo experiments, mathematical and com-
putational modeling are key to unraveling how mechanical and chemical signaling
by endothelial cells coordinates their organization into capillary-like tubes. While
in vitro and in vivo experiments can unveil the effects of for example environmental
changes or gene knockouts, computational models provide a way to formalize and
understand the mechanisms underlying these observations. This chapter reviews re-
cent computational approaches to model angiogenesis, and discusses the insights
they provide in the mechanisms of angiogenesis.
We introduce a new cell-based computational model of an in vitro assay of angio-
genic sprouting from endothelial monolayers in fibrin matrices. Endothelial cells
are modeled by the Cellular Potts Model, combined with continuum descriptions
to model haptotaxis and proteolysis of the extracellular matrix. The computational
model demonstrates how a variety of cellular structural properties and behaviors
determine the dynamics of tube formation. We aim to extend this model to a multi-
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scale model in the sense that cells, extracellular matrix and cell-regulation are de-
scribed at different levels of detail and feedback on each other. Finally we discuss
how computational modeling, combined with in vitro and in vivo modeling steers
experiments, and how it generates new experimental hypotheses and insights on the
mechanics of angiogenesis.
1 Introduction
Blood vessel growth is essential during embryogenesis, but is also a prominent as-
pect of diseases such as cancer, rheumatoid arthritis and retinopathy. Angiogenesis
research can benefit from computational models in three ways. Firstly, computa-
tional models help to gain an overview in this complex system by testing which com-
ponents and interactions are minimally required. These components and interactions
can then be examined to understand their function and predict their effects. Compu-
tational models are therefore not only useful to gain mechanistic understanding of
angiogenesis, but also to find new therapeutic targets. Secondly, computational mod-
els can discriminate between and select from alternative hypotheses. Often, more
than one hypothesis explains a biological observation, such as network formation
from dispersed endothelial cells. Computational models can test the sufficiency of
each hypotheses to reproduce the biological observations. Predictions that result
from these models can be validated experimentally to support or reject the tested
hypotheses. Thirdly, computational models can connect and combine knowledge on
single proteins and mechanisms to examine angiogenesis as a system. Experimental
research is often limited to a specific step or protein in angiogenesis and does not
grasp how this part is integrated in the whole. Ultimately, computational models in-
clude processes at multiple scales, like extracellular matrix, cells, and cell-regulation
simultaneously. Such multi-scale models are the next step in computational model-
ing to make the transition to angiogenesis in the body.
In the first section, computational models of network formation and sprouting are
reviewed. These models address questions that have been raised by experimental ob-
servations and thereby give new insights in angiogenesis. It concludes by discussing
the current state of multi-scale modeling. The next section gives a practical exam-
ple of how computational models can be used in angiogenesis research and shows
how systems biology, a continuous cooperation between computational and experi-
mental biologists, drives development of computational models. To do so, we intro-
duce a new computational model of sprouting, based on an experimental model of
capillary-like tube formation by Koolwijk et al. [19]. Finally we will discuss which
steps should be taken in angiogenesis research to further evolve computational mod-
eling.
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2 Computational models of angiogenesis
The first models of angiogenesis were continuum models that describe angiogenesis
in terms of the spatial density of cells [2, 22, 31, 36]. The main advantage of these
models is that they can often be solved analytically, but they are often too abstract
to mimic angiogenesis realistically. More complex techniques allow for a more de-
tailed description of angiogenesis, which yields more realistic models. Such tech-
niques include discrete methods such as particle based modeling that describe cells
as point-like particles [3, 42] and cell-based models [16, 41, 40] that also explicitly
model the cell shape and membrane. These discrete methods are often combined
with continuum models, creating a hybrid model [4, 6, 24, 29] in order to utilize the
strength of both methods.
This section reviews computational models of angiogenic network formation and
sprouting. Network formation involves the collective behavior of cells and the inter-
action of cells with their environment. Models of sprouting angiogenesis are used to
describe angiogenesis induced by cells in hypoxic tissues, e.g, a tumor.
2.1 Network formation
During early vascular development endothelial cells join into a primitive vascular
network. Vascular network formation can be mimicked in vitro by seeding endothe-
lial cells on a suitable matrix containing nutrients and angiogenic factors; for exam-
ple Figure 1a shows endothelial cells seeded on Matrigel matrix forming a network-
like pattern. The conditions in in vitro network formation experiments differ greatly
from in vivo angiogenesis. Yet, specific cases of angiogenesis result in similar vas-
cular networks such as angiogenesis in the yolk sac and retinal angiogenesis. In both
cases the vasculature arises from a vascular plexus containing endothelial cells.
In vitro experiments showed that, after the network is formed, almost all matrix
is located beneath the cells [46]. This led to the hypothesis that cells pull on the ma-
trix, resulting in matrix accumulation below cell clusters. The pulling forces of the
cells also cause the formation of tension lines, radiating from the clusters, in the sur-
rounding matrix, along which cells migrate [22]. This model assumes that cells can
exert traction on the matrix, which results in matrix deformation and heterogeneity
of strain in the matrix. Cells preferentially move along the orientation of high stress.
The model suggests that matrix remodeling suffices for network formation.
Namy and coworkers combine the effects of cell traction with haptotactic cell mi-
gration along matrix gradients [31] (Figure 1b). They founds an optimal cell density
at which networks can be created, corresponding with experimental observations
[44]. Similarly, a range of matrix stiffness, which is linked to the fibrin density of
the experimental matrix, was tested. This model suggested that active cell migra-
tion may be required for network formation which contradicts the observations by
Manoussaki et al. [22].
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Fig. 1: Overview of vascular network formation. (a) shows a vasculature grown in vitro with
HUVEC on Matrigel. (b) illustrates the networks formed with the mechanical continuum model
[31]. (c) shows the outcome of the chemical continuum model [36]. (d) and (e) show the networks
formed with the chemical cell-based model, respectively with contact inhibition (d) [29] or cell
elongation (e) [24]. (f) illustrates the networks formed with the cell-based model with preferential
attraction to elongated structures [41]. All images were reproduced with the publishers permission.
Both previous models consider mechanical interactions between cells and the
matrix to be the driving forces for network formation. Serini et al. [11, 36] proposed
that chemotaxis is the driving force of network formation [36]. In the in vitro models
cells move predominantly towards regions of high cell density suggesting that the
cells are attracted by a chemoattractant secreted by the cells. Therefore, the com-
putational model assumes that cells secrete a chemoattractant to which cells move
preferentially. This model produces network-like patterns as shown in Figure 1c.
Two important predictions are made based on this model. First, the model predicts
an optimal cell density for the formation of stable vascular networks and second,
the size of the meshes in the network depend on the diffusivity and decay rate of the
chemoattractant.
The mechanical and chemical hypotheses for vascular network formation have
also been combined in one mechanochemical model [43]. This continuum model
hypothesizes that network formation consists of two stages. First, cells move up-
wards chemical gradients. Second, at higher local cell density, the cells do not sense
the gradient, but the high cell density signals them to start remodeling the matrix.
This then attracts cells to the high density regions. The mechanochemical model
showed that the assumptions indeed lead to network formation and that chemotaxis
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drives the formation of networks while mechanical interaction stabilize the formed
network. In this model matrix elasticity does not affect the properties of the net-
works. The mechanochemical model is not able to reproduce all observations from
both chemical and mechanical angiogenesis models; a more detailed description of
the matrix mechanics is required that also influences early cell migration.
Clearly, multiple hypotheses can be used to explain the experimentally observed
network formation. Moreover, model observations and predictions for both the me-
chanical and the chemotaxis model could be reproduced in vitro [31, 36]. The me-
chanical models show that matrix thickness and stiffness may be determining factors
in network formation, as has been show experimentally [46]. The chemical models
reproduce the VEGF dependence that has be observed in vitro [36] as well as a char-
acteristic length of the networks that depends on the diffusivity of the chemoattrac-
tant [1]. Both models only produce one similar prediction; there is an optimal cell
density for network formation, below this density cells disconnect and above this
density cells aggregate [44]. Therefore, it remains unclear whether the two mecha-
nisms are involved in angiogenesis in different environments, or that the two mech-
anism act consecutive or simultaneously during angiogenesis.
Cell-based models The models discussed so far use a continuum description
for both cells and mechanical or chemical fields, meaning that cells and fields are
described as densities. This kind of description is appropriate for mechanical and
chemical fields; for example, the concentration of a specific chemical can be mea-
sured at a specific position and can have any value. However, generalization of cells
into cell densities ignores cell behavior, cell properties and cell-cell interactions,
which are often key to morphogenic processes such as angiogenesis. Therefore,
cells should be the basis of an angiogenesis model. Cell-based models incorporate
detailed cell-cell interactions as well as cell properties such as cell shape and size,
which can also be measured experimentally for quantification of the parameters and
the predictions of the models [27]. Dynamic cell properties and behavior can be
added by extending each cell with regulation networks, such as signaling or genetic
pathways. Altogether, cell-based models are a solid basis for computational angio-
genesis models that can be used to explain tissue effects at the cell level [25].
Different hypotheses have been implemented and compared using cell-based
models. One of these models is a hybrid cell-based model, using the Cellular Potts
Model (see also Section 3.1), which is based on the assumption that cells chemotact
toward a chemoattractant that they themselves secrete [28, 26, 24, 29]. This assump-
tion is similar to the assumption used for the continuum chemotaxis model [36]. In
this cell-based model the cells’ shape, size and membrane surface are described
explicitly, and chemicals are described as continuous fields. One of the main advan-
tages of this cell-based model is the more realistic chemotactic response of cells.
This cell based model can be used to simulate network formation solely by defining
cell behavior and properties. When only autocrine chemotaxis is implemented, net-
work formation only occurs for narrow parameter ranges: strongly adhering cells or
steep chemical gradients [26, 28]. Therefore, Merks et al. proposed two hypothe-
ses for which network formation occurred for a much wider range of parameters:
contact inhibition [29] and cell elongation [24].
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The contact inhibition hypothesis proposes that cells only respond to the au-
tocrine chemoattractants where the cell membrane is not in contact with other cells.
This exclusive sensing is thought to be mediated through the dual function of VE-
cadherin; it acts as a homophilic trans-membrane cell-adhesion molecule and it
plays an inhibitor role in the VEGF signaling pathway [9] which increases cell
motility. Contact-inhibition reduces the motility locally reduces the cell motility.
Therefore, cells within the cluster do not respond to the chemoattractant that all
cells secrete. This process appears to contribute to both network formation (Fig-
ure 1d) and sprouting angiogenesis. The reasons for this are best understood in the
context of sprouting angiogenesis in will therefore be discussed in Section 2.2.
The cell elongation hypothesis is based on the biological observation that cells
elongate during network formation. In this model, the combination of elongated
cells with autocrine chemotaxis results in network formation [24]. The final net-
work, which can be observed in Figure 1e, is similar to in vitro networks. When
cell elongation is omitted, the cells aggregate instead of forming network, indicat-
ing that cell elongation drives network formation in this model. The evolution of
network properties over time, such as the number of nodes and meshes, correspond
with data from in vitro experiments with HUVECs on Matrigel. This suggests that
cell elongation may play an important rule during network formation. In this model
network formation occurs at two time-scales. First, cell elongation induces a per-
sistent movement along the long axis of the cell. This causes the formation of thin
branches of connected cells. Second, the network coarsens by fusion of branches
and mesh collapse. This is driven by the chemotaxis that enables slow migration of
cells along their short axis.
An alternative hypothesis was proposed by Szabo´ et al. [42, 41, 40]. Their exper-
iments suggested that neither mechanical interactions nor chemotaxis are required
for network formation [42] and that cells move preferential towards elongated cells.
From these observation they propose that network formation is driven by the pref-
erential attraction to elongated structures. This hypothesis has been used as a basis
for both a particle based model [42] and a cell-based model [40, 41]. In the particle
based model cells are represented by point particles that diffuse and adhere to their
neighbors. While this model lacks some key cell properties, including cell shape, it
suffices as a proof-of-concept model for preferential attraction to elongated struc-
tures. The models are used both to investigate network formation from dispersed
cells [41] and sprouting from a blob of cells [40]. This model suggests that cells
can indeed form network only due to cell-cell interactions, as is shown in Figure 1f.
Sprouts formed in these networks only become stable when they connect to other
sprouts, suggesting that anastomosis stabilizes the formed network.
Because they all produce similar morphological patterns, none of the modeled
hypotheses can be ruled out as a driving force for network formation. Cell-based
models [28, 26, 24, 29] suggest that autocrine chemotaxis, combined with cell prop-
erties such as contact inhibition of cell elongation, may drive angiogenesis. Other
cell-based angiogenesis model [42, 41, 40] have suggested that autocrine chemo-
taxis may not be necessary at all. Moreover, mechanical interactions between cells
and the matrix have not yet been modeled with a cell-based model. Adding this
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mechanical interaction to cell-based angiogenesis models will help to gain a true
understanding of the mechanisms involved in angiogenesis
2.2 Sprouting
Sprouting angiogenesis is the formation of new vessels by creating a sprout in the
wall of the existing vessel. This form of angiogenesis is often observed in the vicin-
ity of hypoxic tissue that secretes angiogenic factors, e.g., a growing tumor, which
activate and attract endothelial cells from the existing vessels [15].
By stimulating the formation of a new vasculature, a tumor is able to grow and
proliferate. The mechanisms underlying the dynamics of sprouting angiogenesis are
still poorly understood. What mechanisms guide the growing sprout? How do bio-
chemical and biomechanical interactions of the ECM with cells effect sprouting?
Is proliferation required and where is proliferation located in the sprout? How are
tip cells selected in the vessel and what causes sprouts to branch? Computational
models have contributed to a better understanding of these issues.
In corneal angiogenesis sprouting is restricted in absence of proliferation; sprouts
will not reach a tumor when cells are not able to divide [38]. A continuum model
[2] describes the change in cell density over time due to cell migration driven by
cell diffusion, chemotaxis and haptotaxis. The initial configuration of the simula-
tion consists of a blood vessel at one side and a tumor at the other side of the
simulation domain. This tumor secretes a chemoattractant, resulting in a gradient
of chemoattractant that attracts cells towards the tumor. Haptotaxis is induced by
fibronectin that the cells secrete themselves. The highest levels of fibronectin are
present where the cell density is maximum. Therefore, haptotaxis and chemotaxis
work in opposite directions. The continuum model suggests that, in absence of pro-
liferation, the sprouting is restricted. The authors propose that this is caused because
haptotaxis outweighs chemotaxis and increasing the number of cells would increase
the chemotactic response.
A problem with this model is that it describes cells as a density field, hence it
cannot describe how the sprout breaks up due to lack of proliferation. Therefore,
a discrete modeling approach has been introduced to study cell proliferation in the
sprout [16]. As illustrated in Figure 2a, the model mimics a cornea with a lesion in
the center from which VEGF is secreted. A sprout grows from the periphery and
consist of multiple cell types; one leading tip and multiple following stalk cells.
The tip cell migrates towards the center induced by the VEGF gradient. Tip cell
migration is limited by the elasticity of the tip cell and the strength of the adhesion
between stalk cells. Adding proliferation enables unlimited sprout extension. This
model suggests that basic cell properties can explain the need for proliferation in
sprouting.
The model by Szabo´ et al. [40] describes cell shape, cell membrane and cell mi-
gration in much more detail. The model does not consider chemotaxis or cell-matrix
interactions. The cell properties and behavior that are specific for this model are
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Fig. 2: Overview of the computational models of angiogenic sprouting. (a) shows corneal angio-
genesis as modeled in the discrete model based on tip cell elasticity and stalk cell adhesion [16].
(b) shows the networks formed with the discrete model with chemotaxis and fibrinectin induced
haptotaxis [3]. (c) shows sprouting induced by preferential attraction to elongated structures in a
cell-based model [40]. (d) shows the outcome of the cell-based model of sprouting angiogenesis in
a heterogeneous ECM [4]. (e) illustrates how contact inhibition induces sprouting in the cell-based
chemotaxis model [29]. (f) shows how tip cells form sprouts in the agent-based tip cell selection
and sprouting model [6]. All images were reproduced with the publishers permission.
preferential attraction to elongated structures, cell polarity and self-propulsion (i.e.
persistence of motion). The model also differentiates between tip and stalk cells.
The tip cell is polarized, causing directed movement in the direction of the polariza-
tion vector. The results shown in Figure 2c suggest that both preferential attraction
and self-propulsion are necessary to reproduce realistic sprouting behavior. Cell po-
larization may be regulated by cell-cell contacts and VE-cadherin may be a key
player for this. Moreover, the model suggest that differential behavior at the tip of
the sprout may drive sprout formation. Therefore, this model suggests that prolif-
eration may not be required, as long as the supply of cells from the main vessel is
sufficient.
Cell-matrix interactions The previous two cell-based sprouting models have
only considered cell properties and cell behavior, ignoring all ECM and stromal tis-
sue. Anderson and coworkers [3] created a particle based, hybrid model describing
sprouting angiogenesis. In this model cells are represented as point particles on a
grid while the chemotactic and haptotactic fields are still described as continuum
equations. This model was used to investigate how the balance of haptotaxis and
chemotaxis influences branching and anastomosis. As shown in Figure 2b branching
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and anastomosis occur in the model, but these behaviors only occur when cells are
able to move perpendicular to the chemotactic field, which is enabled by haptotaxis.
When the haptotactic forces are strong enough branches can split and reconnect in
order to form a functional vasculature.
Anderson et al.’s model [3] suggests that haptotaxis is key to branching, but it
did not show how cells interact with their heterogeneous environment. A more re-
cent, cell-based model, represents the ECM as a static, heterogeneous configuration
of matrix fiber bundles, interstitial fluid and immobile tissue-specific cells [4]. The
endothelial cells in the model are motile and adhere stronger to matrix fibers than
to the surrounding matrix. Immobile cells act as obstacles that hinder the migra-
tion of endothelial cells. The tip cell is influenced by a chemoattractant field and it
degrades ECM components. Degradation of the extracellular matrix during sprout-
ing enables cells to migrate and branch off the main sprout as shown in Figure 2d.
The model suggests that a heterogeneous composition of the matrix is necessary for
the formation of branches; the inhomogeneities in the matrix enable cells to split
from the main branch. Furthermore, the model suggests that the proliferation region
determines sprouting dynamics but does not affect the final sprout morphology.
A follow-up model was used to investigate cell-ECM interaction in more detail
[5]. In this model all cells respond to the chemoattractant and that the immobile
tissue cells are removed, i.e., only fibers cause matrix heterogeneity. The model
suggests that sprouting only occurs in a specific range of matrix densities, which
corresponds with experimental observations. Moreover, simulation results suggest
that low fiber density results in cell elongation. Similar changes were observed when
the random fibers were replaced by a specific fiber pattern, for example long fibers
cause cells to elongate in the same direction as the fibers. The authors propose that
contact guidance, due to cell-matrix interactions, is key to role in vascular sprouting
because it enables sprout branching in an inhomogeneous matrix.
Another model suggests branching can occur in the absence of matrix hetero-
geneity [29]. The model assumes cells are attracted towards an autocrine chemoat-
tractant, using similar rules as in chemotaxis-based network model (Section 2.1).
Contact inhibition mediated by VE-cadherin causes cells to be only sensitive to the
chemoattractant at positions of the cell membrane adjacent to the ECM. Sprouting
occurs in two ways. First, when cells are arranged in an aggregate, only the outer
layer of cells sense the chemoattractant. These cells tend to migrate towards the
center of the aggregate causing a buckling instability that induces sprouting. This
effect enables cells, even those with a low motility, to move against the chemotactic
gradient. Second, another mechanism may explain sprouting for highly motile cells.
To move away from the mother vessel and form a sprout, cells must migrate against
a steep gradient of self-secreted chemoattractant. Once a small sprout is created by
a motile cell, the gradient around this outgrowth is less steep than the rest of the
gradient, so cells within the sprout have higher motility than elsewhere, causing an
instability.
Although all previous models simplified angiogenesis by assuming endothelial
cells all have identical properties, in fact differentiation between leading “tip” cells
and following “stalk” cells is key to sprouting angiogenesis. Bentley et al. [6] inves-
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tigate the molecular and biophysical mechanisms driving tip and stalk cell differen-
tiation using an agent-based, computational model [6]. The model represents a row
of cylindrical endothelial tip and stalk cells made up of multiple agents. Only the
tip cells can extend filopodia outwards, representing an new sprout as shown in Fig-
ure 2f. The model is used to study the interaction between Dll4-Notch1-signaling
with VEGF-induces tip cell activation [14]. The robustness of tip cell selection is
investigated by applying a VEGF gradient perpendicular to the vessel [7] ; each cell
senses the same level of VEGF, which combined with a Dll4-Notch1-based lateral
inhibition mechanism produces a pattern of alternating tip and stalk cells. The tip
cells grow long filopodia that may meet up to form a connected vessel; anastomosis.
When the common surface area of the connecting tip cells has increased sufficiently,
one of the two cells becomes a stalk cells and the vessel stabilizes. Thus, the model
suggests that the common surface area is a determining factor for tip cells selec-
tion; if the common surface area is too small lateral inhibition does not work. A
second application of the model involved cellular competition for the tip cell po-
sition. Time-lapse microscopy has shown how stalk cells migrate along the sprout,
take up the role of tip cell, and inhibit the original tip cell become a stalk cell [17].
Cell variants with higher levels of VEGFR2-expression have a competitive advan-
tage over the wild-types: they end up more often at the tip of the sprout, but only if
Notch1 can inhibit Dll4 expression. The advantage of the variants diminishes when
all cells have low levels of Notch1. These observations suggest that Notch limits the
levels of VEGFR2 in wild-type cells. Bentley test this hypothesis in her agent-based
angiogenesis model by applying a VEGF gradient along the sprout and by allow-
ing cells to switch places. Switching is regulated the level of VEGFR2 and Notch
expression; VEGFR2 promotes switches towards VEGF while Notch1 inhibits the
same switches. With these assumptions the experimental observation could be re-
produced, suggesting that this mechanism may explain tip cell shuffling.
2.3 The future of angiogenesis modeling
The models discussed sofar, all isolated specific aspects of angiogenesis to predict
the outcome of proposed in vitro experiments. To study angiogenesis in vivo, we
must incorporate the interaction with the rest of the body in a multi-scale model.
Angiogenesis is induced by hypoxic tissue which, for example, can be a tumor or an
active muscle. The change in oxygen and nutrient supply due to the new vasculature
changes the signals coming from the tissue, resulting in a dynamic feedback loop
between angiogenesis and the needs of the tissue. Also blood flow may be key to
this feedback. Disfunctional vessels are not able to support blood flow and do not
contribute to the perfusion of the tissue. Endothelial cell change their behavior due
to the shear stresses induced by blood flow [10]. The inclusion of these processes
in a multi-scale angiogenesis model would be a great tool to study whether patho-
logical processes either involve excessive or insufficient blood vessel growth. Such
multi-scale models can not only be used to formalize and validate hypotheses, they
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can also be used to predict the effects of pro- or anti-angiogenic therapies on the
vasculature and the other tissues involved.
In order to build these multi-scale models, researchers often extend existing mod-
els. For example, the particle-based sprouting model by Anderson et al. [3] has been
extended with blood flow [23]. This model suggested that most vessels are not per-
fused due to the lack of anastomosis, and thus drugs can not reach the target. More
complex approaches have been used to combine more detailed angiogenesis models
with blood flow and the kinetics of oxygen and VEGF [33, 34, 32]. This model has
show to produce vascularization similar to experimental observation in a heteroge-
neous extracellular matrix [34] and in the skeletal muscle [21].
In the previous models the surroundings of the vasculature are static and are not
being changed by the growing vessels and the increasing supply of oxygen and nu-
trients. This means that a part of the feedback is missing, for example a tumor can
grow when the blood supply increases and a larger tumor needs a bigger supply of
blood. Shirinifard et al. [37] combined cell-based Cellular Potts models (see Section
3.1) of blood vessel formation and tumor growth to investigate how tumor growth
and vascular remodeling interact. This high level of detail gives insight in how spe-
cific cell properties influence tumor growth and angiogenesis.
Cell-based modeling would be a suitable approach to create predictive multi-
scale models. Cell behavior in such a model must be linked to biological or physical
cell properties. The extracellular matrix as well as blood flow could be added to
the model. Then, the cell properties could be linked to matrix interactions and local
levels of oxygen, nutrients and other chemicals. A cell-based model could simulate
emergent angiogenesis and blood vessel remodeling and could be used to predict
the effects of therapeutic agents.
3 Cell-based model of in vitro sprouting
The previous section discussed how multi-level computational models aim to fuse
models to incorporate different aspects of angiogenesis, such as cell behavior, ma-
trix interactions and blood flow. Processes like chemotaxis and haptotaxis can be
described with continuum models, while we argued that the representation of cells
requires a cell-based approach. Cell-based models explicitly model cell structures
(e.g. cell membranes) and cell behaviors (e.g. cell-cell adhesion and pseudopod ex-
tensions). These models are intuitive and relate well with biological observations.
To illustrate the approach, we created a computational cell-based model of an in
vitro model of capillary-like tube formation, introduced by Koolwijk et al. [19].
A schematic representation of a cross-section of the experimental model is
given in Figure 3. A monolayer of isolated human microvascular endothelial cells
(hMVEC) is seeded on a three-dimensional fibrin matrix. The composition of this
matrix, consisting of only fibrin (Figure 7), is completely controlled and repro-
ducible. The endothelial cells grow into the matrix and form capillary-like tubular
structures upon stimulation with an angiogenic factor, VEGF and/or bFGF (basic
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Fig. 3: A schematic cross-section of the experimental model by Koolwijk et al. [19]. Endothelial
cells are seeded on a three-dimensional fibrin matrix and form capillary-like tubular structures
upon stimulation.
fibroblast growth factor), in combination with the inflammatory mediator TNFα
(tumor-necrosis factor alpha). TNFα is suggested to induce receptor-bound u-PA
(urokinase-type plasminogen activator) activity to enable the cells to degrade the
fibrin matrix [45]. Although VEGF and bFGF are both growth factors, TNFα com-
pletely inhibited the growth factor-induced proliferation in this experimental model.
The computational model of sprouting is designed to be easy to relate to the
experimental observations. The model can be used to explain and predict angiogenic
patterning on tissue level, based on quantitative descriptions of cell behavior. The
most important cell behaviors, such as cell shape, cell adhesion and haptotaxis are
therefore included, and their effects and relative importance in sprouting can be
examined. Endothelial cells have a wide range of interactions with the extracellular
matrix, of which the function as well the effects are often still unclear. Endothelial
cells for instance secrete proteolytic enzymes to degrade the matrix. The proteolytic
activity is regulated by a complex system and the computational model can help
to gain insight in the relative importance of the components in this system, in the
regulation of the system and in the effect of this regulation on sprouting.
3.1 Computational sprouting model
To mimic the experimental set-up of Koolwijk et al., the computational model starts
with a monolayer of cells, of which one is a tip cell and the rest are stalk cells,
on a fibrin matrix and a basement membrane (BM) in between. The Cellular Potts
model [12, 13] describes the shape, behavior and movement of the cells. The tip cell
will secrete proteolytic enzymes, MMPs (matrix metalloproteinases) and u-PA, to
degrade the BM and fibrin respectively. The endothelial cells are attracted to higher
concentrations of fibrin, which is also modeled as a concentration field, and migrate
into the created space to form a sprout. On top, a local chemorepulsive field exerts a
small pressure on the endothelial cells in the monolayer to keep them flattened and
well connected. A schematic overview of the model is given in Figure 4.
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Fig. 4: Schematic representation of the Cellular Potts model. The different colors depict the types
defined in the sprouting model. The tip cell secretes MMP and u-PA (large arrows) to degrade the
extracellular matrix and the small arrows on top represent a the small chemorepulsive pressure on
the cells.
The Cellular Potts model represents cells, BM and fibrin as patches of grid sites
(Figure 4), which are differentiated by types (τ) with specific properties and be-
haviors. Cells can migrate by the addition and removal of grid sites at their cell
membranes, which can be seen as extensions or retractions of pseudopodia. A
grid site (x) is added or removed by copying the contents of a neighboring grid
site (x’) (Figure 5). Whether such a copy is allowed depends on an energy func-
tion, which summarizes the balance of forces resulting from cell behavior: E =
Econtact+Eshape+Econnectivity. The change in this local energy (∆E) for a certain copy
is a measure for its favorability. Energy decreasing copies will always be accepted;
while a copy that increases energy will be accepted according to a Boltzmann prob-
ability function: Paccept(∆E) = e
−∆E
µ . The ability to accept copies that cost energy
resembles active cell motility, with the parameter µ a cell motility parameter.
Fig. 5: Graphical representation of a copy
attempt. A random grid site (x) is chosen
to copy the state of a neighboring grid site
(x′) to simulate pseudopod extensions and
retractions.
Adhesion or repulsion by cells is modeled by contact energy between types
(Jτ1,τ2): lower energies resemble stronger adhesions between types. The model is
surrounded by a border (Figure 4) which has high contact energy with cells to pre-
vent them from sticking to the edges. The overall contact energy sums the contact
energies between cells and between cells and their surrounding:
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Econtact = ∑
(x,x′)
Jτ(x),τ(x′),
with (x,x′) a pair of adjacent grid sites at the cell membrane. Migrating cells
have a typical shape, depending on cell size (area) and membrane surface (perime-
ter). Therefore, the energy increases with the deviation of a target value. λarea and
λperimeter indicate the weights of the constraints.
Eshape = ∑
c ∈ cells
λarea(τc)
(
A(c)−Atarget(τc)
)2+λperimeter(τc)(P(c)−Ptarget(τc))2
Biological cells do not break up, thus all pixels of one cell must be connected.
Therefore, a large penalty energy (Econnectivity; see Table 1) is added to the energy
function when a tip or stalk cell has lost its connectivity [39].
The tip and stalk cell are surrounded by extracellular matrix, that is fibrin or BM.
Unlike the migrating cells, fibrin and BM are immobile types. Endothelial cells can
preferentially migrate towards higher concentrations of adhesion sites in the extra-
cellular matrix, this process is called haptotaxis. In order to model this, fibrin and
BM are also modeled as static homogeneous concentration fields that attract tip and
stalk cells. The tip cell secretes u-PA and MMP to locally degrade the concentra-
tion fields. The probability that the types ’fibrin’ and ’BM’ are degraded depends
on their local field concentrations by a Hill equation: Pdegradation of X =
[X ]n
[k]n+[X ]n . The
concentrations of the proteolytic enzymes are described by the following partial dif-
ferential equation: δcδ t = D∇
2c+ kc+ sτ , where D refers to the diffusion constant,
k to the decay constant and s to the secretion of the enzyme c by type τ . The local
degradation of the haptotactic fields by the secreted proteolytic enzymes results in
concentration gradients, a cell will preferentially extend up the gradient [35]. The
effect of haptotaxis is calculated for every copy attempt. Chemotaxis and haptotaxis
are implemented as:
∆E = Enew−Eold−∆Ehaptotaxis ,where ∆Ehaptotaxis = λhaptotaxis
(
c(x′)− c(x)),
with c the concentration of the attracting component and λhaptotaxis describes the
weight of the constraint.
3.2 Integration of the experimental and computational model
In section 3.1, we showed how a conceptual model of tube formation translates
to a computational model. Basic cell behaviors and properties are included in the
computational and the default parameters can be found in Table 1. First, the model
is used to test a hypothesis concerning the relation of proteolytic enzyme secretion
and sprout morphology. Subsequently, the model will be extended, mainly focusing
on matrix interactions, to differentiate between forces that drive migration. With
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Table 1: Default parameters for the sprouting model.
Property Value
Contact energy Jstalk,medium = 1, Jstalk,tip = 1, Jtip,BM = 100
Jstalk,border = 107, Jstalk,pressure = 107, Jtip,border = 107, Jtip,pressure = 107
Area Atarget(tip,stalk) = 50, λ (tip,stalk) = 70
Perimeter Ptarget(tip,stalk) = 30, λ (tip) = 25, λ (stalk) = 5
Haptotaxis λ (tip,stalk) = 1000
Chemotactic pressure λ (tip,stalk) =−0.1
Pressure field D= 10−2, k = 0.01, s= 1000
MMP and u-PA field D= 10−6, k = 0.01, s= 500
Fibrin degradation type: n = 4, k = 1.9, initial concentration = 2
field: −10−7 · [u-PA][fibrin]
BM degradation type: n = 3, k = 1, initial concentration = 2
field: −5∗10−8 · [MMP][BM]
these examples, we emphasize how computational and experimental biologists can
benefit from each other’s models in their quest to understand angiogenesis.
3.2.1 Matrix degradation and sprout morphology
To induce sprouting, endothelial cells are stimulated with an angiogenic factor,
VEGF and/or bFGF, in combination with the inflammatory mediator TNFα [19, 8].
Both the angiogenic factors as well as TNFα induce proteolytic enzyme activity.
The growth factors are suggested to stimulate secretion of a soluble form of plas-
minogen activators, t-PA (tissue plasminogen activator), which becomes active upon
contact with fibrin and degrades fibrin in a diffuse manner. TNFα is suggested to in-
duce u-PA (urokinase-type plasminogen activator) production and thereby stimulate
receptor-bound u-PA activity [19]. u-PA is inactive until it is bound to its membrane-
bound receptor, which localizes proteolytic activity to the membranes of the recep-
tor expressing cells. Besides u-PA, TNFα can also induce the plasminogen activator
inhibitor, PAI-1, which inhibits u-PA and t-PA. Proteolytic activity during sprouting
is closely regulated by endothelial cells and results from a balance between the
proteolytic enzymes and their inhibitors. Endothelial cells secrete MMPs (matrix
metalloproteinases) to degrade the basement membrane. The production and activ-
ity of u-PA and MMPs is interlinked; u-PA activity is suggested to induce MMP
activity indirectly and at least one membrane-bound MMP (MT1-MMP) is known
to be capable of fibrin degradation as well [47].
Proteolytic activity can be manipulated by stimulation the cells with angiogenic
factors or inflammatory factors [8]. To induce sprout formation, low amounts of
TNFα are added to the monolayer of endothelial cells in combination with a growth
factor. Stimulation with angiogenic factors alone induces a uniform degradation of
fibrin and the monolayer of endothelial cells does not sprout but as a result lowers
as a whole. This uniform degradation of fibrin can result from a combination of
diffuse proteolysis induced by the angiogenic factors and the absence of inflamma-
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tory factor induced inhibitors of proteolysis. Excessive plasminogen activation, in
endothelial cells seeded in suspension into a three-dimensional fibrin matrix, results
in the formation of round cyst-like structures [30]. Cyst-like structures are also ob-
served in the endothelial monolayer model [19] after stimulation with a higher dose
of TNFα in combination with angiogenic growth factors by Koolwijk et al. (data
not shown).
We aim to find the conditions that is suffice to explain the experimental obser-
vations on sprout morphology. This hypothesis will then be tested with the compu-
tational model. We hypothesize that the intensity of proteolytic enzyme secretion
(u-PA and MMP) as well as the distribution of secretion over different cell types is
responsible for the observed phenotypes in angiogenesis. After low stimulation with
TNFα , tip cells might already secrete proteolytic enzymes at maximal rate and are
therefore insensitive to stimulation. In contrast, stalk cells normally do not secrete
many proteolytic enzymes and are therefore more sensitive for stimulation than tip
cells. Indeed, the tip cell was seen to have the most u-PA receptors during sprout-
ing, which facilitate proteolysis to degrade fibrin [20]. When both tip and stalk cells
secrete high levels of proteolytic enzymes, the fibrin will be degraded uniformly.
To test this hypothesis in the computational model, we assumed that both tip
and stalk cells can secrete u-PA and MMP. As discussed above, proteolysis is a
complex system that involves membrane-bound and soluble proteolytic enzymes as
well as inhibitors. For simplicity, only membrane associated proteolytic activity and
no inhibitors are considered in this first attempt. Since inhibitors are not modeled
explicitly, proteolytic activity and secretion of proteolytic enzymes are directly cou-
pled. The presence of inhibitor is modeled by lower secretion rates of the proteolytic
enzyme. To model proteolytic activity at the membrane, the diffusion constants for
the proteolytic enzymes are set to a very low value (Table 1). Secretion of the prote-
olytic enzymes could also be thought of as expression of the receptors that facilitate
the activity of the enzymes at the membrane. Soluble proteolytic enzymes are not
modeled, although high secretion of proteolytic enzymes does result in proteolytic
activity at a larger distance. MMPs are assumed to exclusively degrade the base-
ment membrane, while u-PA degrades the fibrin matrix. Mitosis of stalk cells is also
included in the model to supply the monolayer with new cells, simply by dividing
a cell over its short axis when it has increased by an arbitrary factor of 1.28. The
secretion of the proteolytic enzymes by the tip cell is kept constant at a maximal
rate.
We study how u-PA and MMP secretion by stalk cells affects sprout morphology.
Figure 6 gives an overview of the simulation results as a function of the secretion
rates of u-PA and MMP. Because the simulations are stochastic, variation is seen
between simulations with the same parameter settings; representative simulations
were selected for the morphospace in Figure 6. Sprout morphology can be grouped
in four categories: sprouts, solid round cysts, hollow cysts and monolayers. Sprouts
have a cord-like orientation of cells, while cysts are more round and multi-cellular. A
high secretion of both u-PA and MMP (Figure 6D) by stalk cells results in lowering
of the monolayer. Sprouts are formed for low secretion of u-PA (Figure 6A), while
solid cyst-like structures are formed for medium levels of u-PA secretion (Figure 6B)
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Fig. 6: Morphospace of proteolytic enzyme secretion by stalk cells. Tip and stalk cells secrete u-PA
and MMP to degrade fibrin and the basement membrane respectively. The secretion of u-PA and
MMP by stalk cells is expressed in percentage of the maximal secretion rate as secreted by the
tip cell. This results in different sprout morphologies: sprouts (A), solid cyst-like structures (B),
hollow cyst-like structures (C) and monolayers (D).
for all MMP secretion levels by stalk cells. High secretion of u-PA and low secretion
of MMP (Figure 6C) results in hollow-cyst like structures. Occasionally (6 out of
128 simulations), no sprouting occurs for low levels of MMP secretion by stalk
cells because stalk cells position themselves between the tip cell and the BM and
thereby prevent degradation of the basement membrane. An interesting transition is
seen between a hollow cyst-like structure and monolayer lowering for a secretion of
MMP between 8% and 12%. The hollow cyst-like structures can be formed since the
BM remains intact for attachment of endothelial cells before this transition. These
structures are likely to collapse if gravity was included in the model. Experimentally,
tubular structures can also disappear due to excessive fibrinolysis [8].
u-PA can activate MMP, thus the activity of both enzymes are likely to increase
simultaneously. The sprout morphologies that are seen along diagonals of the mor-
phospace in Figure 6 are therefore biologically most probable. Along the diagonal,
we see sprout formation for low secretion of both enzymes by stalk cells, cyst for-
mation for medium secretion and monolayer lowering for high secretion. This is
consistent with the experimental results by Collen et al. [8] and our own as discussed
above. The intensity and the distribution of proteolytic enzyme secretion over dif-
ferent cell types (tip and stalk cells) thus seems to be a sufficient explanation for the
tissue behavior observed in the laboratory.
The computational model is oversimplified, because it only describes proteolytic
activity at the membrane and no diffuse matrix degradation or inhibitors. The no-
tion that TNFα induces secretion of proteolytic enzymes as well as their inhibitors
implicates a more complex regulation of matrix degradation during sprouting. Low-
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ering of the endothelial monolayer, when exclusively stimulated with angiogenic
factors, is likely to depend on soluble rather than membrane-bound proteolytic en-
zymes. Inhibitors and soluble proteolytic enzymes should be included to understand
the basic principles of angiogenesis.
Fig. 7: Fibrin matrices. Scanning electron microscopic analysis of fibrin networks. High molecular
weight (HMW) fibrinogen is thicker and forms more open network structures (left Figure) than
low molecular weight (LMW) fibrinogen (right Figure). Bars represent 1 µm.
Beside proteolytic degradation of the extracellular matrix, it is likely that the
structure of the matrix influences tube formation. Matrix structure for example ef-
fects the sensitivity of fibrin matrices to proteolytic degradation [8]. The composi-
tion of fibrin matrices can be controlled experimentally [18]. High molecular weight
(HMW) and low molecular weight (LMW) fibrinogen can be isolated from unfrac-
tionated fibrin and used to create different densities of the matrix. A matrix com-
posed of only LMW fibrinogen has thinner fibers and has a denser structure than a
matrix made from only HMW fibrinogen (Figure 7). Small differences in fibrin ma-
trix lead to different gene expression patterns in endothelial cells [47] and influence
tube formation [18]. Tube formation was more extensive in HMW than in LMW
matrices. We plan to use the computational model to examine how these differences
in matrix structure influence sprouting.
3.3 Modeling perspectives
Koolwijk et al. developed a simple in vitro model to examine tube formation in an-
giogenesis [19]. To gain knowledge in the mechanism and key players involved, we
created a computational model that resembles the experimental in vitro model. The
computational model is used to validate conceptual models for basic mechanisms of
sprouting and to predict how alterations in cell behavior will affect sprouting. The
model explains experimental observations concerning the effects of proteolytic en-
zyme activity on sprout morphology by supporting the hypothesis that not only the
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level, but also the distribution of proteolytic enzyme secretion over tip and stalk cells
is responsible for different sprout morphologies. Several experimental observations
and techniques can help to validate conclusions drawn from the model. Contradic-
tions between experimental data and the computational predictions point out gaps
in our understanding. A clear focus point for improvement is the structure of the
extracellular matrix and the interactions of cells with the matrix.
We currently model the extracellular matrix in more detail. Endothelial cells
strongly interact with the matrix, mechanically as well as chemically. Cells can ad-
here to the fibers in the matrix and rearrange the fibers. By modeling the actual fibers
and their alignment, physical obstruction of the matrix, haptotaxis and directional
guidance of migration can be considered. Endothelial cells can also degrade the ma-
trix with a sensitive and complicated system of proteolytic enzymes. Proteolysis of
the matrix locally releases chemotactic components that stimulate sprouting. Each
of these mechanical, haptotactical and chemotactical forces resulting from the sur-
rounding tissue influence angiogenesis and are therefore important to understand.
Besides modeling the extracellular matrix more intensively, the interactions
within the cell should be focused on. Endothelial cells adhere to the extracellular
matrix with integrins, which are also linked to the cytoskeleton of the cell. By mod-
eling cytoskeleton remodeling and integrin-mediated binding at a molecular level,
we can study mechanical matrix interaction. Additionally, tip cell selection is an
interesting molecular interaction within and between cells to include in the model.
Tip cell selection depends on Delta-Notch signaling [14] and is required for experi-
mentally observed branching of tubes.
In conclusion, we aim to create a multi-level model of angiogenesis that includes
the molecular, cellular and tissue level. Each level should be modeled simple and
intuitively and the interaction between the levels must be taken in close considera-
tion. To understand which components should be modeled and how they interact, a
continuous feedback between experimental and computational modelers is needed.
4 Conclusion
In this chapter, we have reviewed how computational models shed new light on
questions involving network formation and sprouting. Firstly, we discussed how
computational models are used to test alternative hypotheses on the mechanisms
that drive network formation. Cellular and environmental factors in these models
are studied to predict their effects on angiogenesis. A comparison of experimental
results and these computational predictions can show which mechanisms are most
likely the driving forces of network formation. Secondly, we focused on compu-
tational models that provide new insights in the mechanisms of sprouting. These
models shed light on questions about the regulation of sprouting, such as the neces-
sity and location of proliferation, dynamics of tip cell selection, and the influence
of angiogenic factors and the extracellular matrix. The discussed models use differ-
ent techniques to model cells: continuum models describe cells as densities, while
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discrete models represent them as particles. The functioning of endothelial cells
dependents on thousands of interacting proteins and genes. Cell-based models are
discrete models that represent the results of these gene and protein interactions by
a set of cell properties (e.g. cell and membrane size) and behaviors (e.g. adhesion
and chemotaxis), suggesting that a few cell behaviors sometimes suffice to explain
complex collective cell behaviors like angiogenesis [25].
To illustrate this approach in more detail, we created a cell-based model to study
angiogenic sprouting. This computational model is based on an in vitro model of
sprouting in a fibrin matrix by Koolwijk et al. [19]. The model is used to formalize
the mechanisms that are minimally required for sprouting and it predicts the effects
on the dynamics of tube formation of varying cell properties, such as matrix degra-
dation. Predictions from the model can lead to new insights and drive experimental
research. The observations and results from the experimental research are crucial for
the validation and further development of the computational model. A focus point
for further study is the interaction of endothelial cells with the extracellular matrix.
Various interaction with the matrix strongly influences sprouting, but it is difficult to
separately study them experimentally. We plan to model the extracellular matrix it-
self and its interactions with endothelial cells in more detail and extend our model to
a multi-scale model, including molecular, cellular and tissue levels, to gain insight in
these interactions. In a close cooperation between experimental and computational
biologists, we can reach a thorough understanding of how the interactions between
multiple levels of organization lead to counterintuitive effects, which experiments
alone would not unveil.
Multi-scale modeling is thought to be the next step in computational modeling. If
different scales and their interactions are modeled simultaneously, we can identify
the global and local (side) effects of a therapeutic drug. Some multi-scale models of
angiogenesis have already been developed [23, 33, 34, 32, 21, 37], as discussed in
section 2. So far, many of these models are based on phenomenological rules and
the results are direct results of the implemented rules. In order to make the step to
explanatory rather than descriptive multi-scale models, a thorough understanding of
the mechanisms at the separate levels is needed. A few international projects rec-
ognize this need for explanatory multi-scale models, like the Physiome Project and
the Virtual Physiological Human Project [21]. We argue that cells and their behav-
ior should still have a central role in these models, since cell behaviors and prop-
erties can also be observed and measured experimentally, which allows validation
and quantification of the computational model. A constant feedback loop between
computational and experimental models is thus needed to reach a functional and
multi-level understanding of angiogenesis, a strategy called systems biology.
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